In this Issue
Lykos Scales Back Investigator-Initiated Trials Program, Refers Some Researchers to PharmAla
Lykos Appoints ‘Pharma Veterans’ to C-Suite
Psyence Scoops Up Clairvoyant for Peanuts
Mindstate’s Moxy Enters Phase I Trial
Embattled Braxia Bought for $180k
UK Gov. Unveils £400m Plan to Catalyse Clinical Trials
GH Research Waiting on Tox Studies to Respond to FDA’s Clinical Hold
Cydex Sues Bexson Over Psychedelic Salt Patents
Other Stories
***
Lykos Scales Back Investigator-Initiated Trials Program, Refers Some Researchers to PharmAla
Sign-in or join Pα+ to continue reading this Issue of the Psychedelic Bulletin…
Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and culture.
Subscribe AnnuallySubscribe Monthly
Already a member? Log In
✓ Regular Bulletins covering key topics and trends in the psychedelics space✓ Regular articles and deep dives across psychedelic research, policy and business✓ Interviews with insiders✓ Monthly interactive database and commentary on psychedelic patents✓ Quick-take analysis of major developments✓ A Library of primers and explainers✓ Access to our full back catalogue
Learn more about Pα+
